https://www.theglobalfund.org/media/9629/covid19_diagnosticproducts_list_en.pdf
New link!
Nice to see genesig make the list!
A £7BN Testing fund!!!
The ACT-Accelerator is on the cusp of securing a way to end the acute phase of the pandemic by deploying the tests, treatments and vaccines the world needs
https://theglobalfund.org/media/9629/covid19_diagnosticproducts_list_en.pdf…
Nice!!??
Primerdesign USA
There are 74 patent applications and 29 granted patents matching the keywords Primerdesign. Https://uspto.report/patent/search/Primerdesign
The four NAT assays were able to detect early viremia 40-66 hours earlier than the 1,000 copies/mL infectivity threshold, whereas the three antigen tests would become positive 41-48 hours later
news-medical.net
Study shows that nucleic acid amplification tests more accurate in detecting SARS-CoV-2 than rapid...
Life after covid!
Numbers below add up to a hell of a lot of testing!!!??
The centre is one of 43 nationally that the government has funded to provide diagnostic services closer to patients' homes.
Together, these new facilities will have the capacity to deliver up to 800,000 additional tests nationally by March 2022. https://ouh.nhs.uk/news/article.aspx?id=1678&pi=0&returnurl=/news/default.aspx
BioFire’s test, meanwhile, received a de novo clearance, which creates a simpler pathway to approval for other coronavirus diagnostics. Future tests would only have to prove they are substantially equivalent to the first approved product https://www.fiercebiotech.com/medtech/fda-grants-its-first-full-approval-to-a-covid-diagnostic-test
Achieving a sustainable aviation industry requires energy efficiency improvements in aircraft technology and better operations. In the future, electric and hydrogen-powered aviation may unlock affordable and convenient local and regional travel. But for today’s long-distance travel, we need bold partnerships to spur the deployment of billions of gallons of sustainable aviation fuels quickly.
Fuel Providers Will Scale Up SAF Production
Current levels of domestic SAF production are approximately 4.5 million gallons per year, with the industry poised to grow rapidly. To meet the challenge of scaling up to billions of gallons over a decade, both policy support and producer commitments will be critical to driving domestic innovation and deployment. Scaling up domestic SAF production will involve a wide variety of different feedstocks and pathways, and the industry will continue to explore a diverse set of options, including the potential to convert biofuels such as ethanol into jet fuel. To help achieve our 2030 goals, several fuel providers have announced domestic SAF production targets:
LanzaJet plans to produce 1 billion gallons of SAF per year 2030 from ethanol derived from waste sources by Alcohol-to-Jet processing.
World Energy plans to produce 150 million gallons of SAF per year by 2024 from fats, oils, and greases by hydroprocessing.
Gevo plans to produce over 150 million gallons of SAF per year by 2025 from crop residue to ethanol by Alcohol-to-jet processing.
Fulcrum plans to produce more than 33 million gallons of SAF per year by 2022 from MSW processed by Fischer-Tropsch processing.
Velocys plans to produce 300 million gallons of blended SAF per year from waste woody biomass and MSW processed by Fischer-Tropsch processing.
https://www.whitehouse.gov/briefing-room/statements-releases/2021/09/09/fact-sheet-biden-administration-advances-the-future-of-sustainable-fuels-in-american-aviation/
Right area!, right time!, This co has got legs!!!!??
Glasgow COVID-19 Lab Passes 20 Million Tests
Health and Social Care Secretary meets staff to thank them for their vital work in stopping the spread of COVID-19 https://www.gov.uk/government/news/glasgow-covid-19-lab-passes-20-million-tests?utm_medium=email&utm_campaign=govuk-notifications&utm_source=bd0c84a2-2a97-4f13-a9e5-93d7ae250aec&utm_content=immediately
A sub-lineage of the UK’s Alpha SARS-CoV-2 variant known as B.1.1.7, the variant is likely the culprit triggering huge surges in infections and possibly even the rising death rates in places such as Austria https://trialsitenews.com/european-study-alpha-variant-likely-evading-vaccines-wreaking-havoc-in-europe/
“Market is heading towards valuing the company only for its cash at bank”
So would you say the whole group of diagnostic companies under Novacyt’s wing are worth nothing???
Novacyt is now simply a cash cow!, we now just need to wait and see how much grass its been chewing through!??
Imo Dispute and miscommunication is holding us back, nothing more!!!!!
This rising demand is attributed to affordability of the PCR segment. Geographically, North America region led the global molecular diagnostics market with a major share of 39.1%. This lead is credited to the rising cases of contagious diseases in the region. Besides, the government is also taking several initiatives to make masses aware about the technology, propelling the additional growth rate in the regional market. https://www.biospace.com/article/molecular-diagnostics-market-developing-genetic-engineering-to-provide-essential-boost-to-the-market/
Sorry should have posted link first time!??
https://www.med-technews.com/news/Medtech-Diagnostics-news/government-to-provide-nhs-with-248m-for-more-diagnostics/
The NHS will receive £248 million over the next year to invest in technology that will deliver more diagnostic tests, checks and scans to help provide faster diagnosis of a health condition, earlier treatment and reduce waiting lists.
The announcement follows the £2.3 billion investment announced at the latest Spending Review over the next three years to transform diagnostic services with at least 100 community diagnostic centres across England – helping millions of patients access earlier diagnostic tests closer to home
https://mobile.twitter.com/toutoupepere/status/1456445761063956484/photo/1
Info courtesy of toutou on twitter!??
Qiagen (http://QIA.DE) on Wednesday raised its full-year forecasts for profit and revenue, with higher demand for its non-coronavirus products as well COVID-19 tests helping the U.S.-German genetic testing specialist beat expectations Https://www.reuters.com/business/healthcare-pharmaceuticals/qiagen-q3-profit-surges-covid-19-testing-demand-2021-11-03/?rpc=401&